Alyeska Investment Group, L.P. Protara Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$13.75 - $23.86 $481,250 - $835,100	35,000 Added 47.04%	109,405 $1.72 Million
Q4 2020 Feb 16, 2021	SELL	$16.97 - $25.34 $2.13 Million - $3.18 Million	-125,595 Reduced 62.8%	74,405 $0
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $3.35 Million - $6.38 Million	200,000 New	200,000 $0

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $53M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.